FDA NDC
Breo Ellipta
This name is from the loaded FDA file.
Source: FDA NDC Directory, live from openFDA. Publisher page
- NDC
- 0173-0882
- Proprietary name
- Breo Ellipta
- Nonproprietary name
- fluticasone furoate and vilanterol trifenatate
- Labeler
- GlaxoSmithKline LLC
- Dosage form
- POWDER
- Strength
- 200 ug/1
Run it in Rivvi
Which 2027 plans near you dropped or restricted fluticasone furoate and vilanterol trifenatate?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.